# A Novel Iron Supplement for Athletes: Phase I

> **NCT06285851** · NA · COMPLETED · sponsor: **University of Calgary** · enrollment: 14 (actual)

## Conditions studied

- Constipation
- Diarrhea
- Cramp, Abdominal
- Bleeding Gastric

## Interventions

- **DIETARY_SUPPLEMENT:** FeSC

## Key facts

- **NCT ID:** NCT06285851
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-23
- **Primary completion:** 2023-12-12
- **Final completion:** 2023-12-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285851, "A Novel Iron Supplement for Athletes: Phase I". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06285851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*